PARIS and CAMBRIDGE, Mass., March 12, 2018 /PRNewswire/ —
Enterome SA, a clinical-stage biotech company pioneering innovative therapies to treat microbiome-associated diseases with a focus on inflammatory bowel diseases (IBD) and immuno-oncology (IO) indications, will present at the…
